Crypto
Injective Price Surges Amid ETF Listing Hopes and Network Upgrade
Injective (INJ) is trading at $8.07, rising 7.94% on the day and holding above its key moving averages.
The asset's price is currently on the strong side of its recent trend structure.
The proposed listing of a spot Injective ETF on Nasdaq by 21Shares could broaden institutional access to Injective and increase demand, giving mainstream investors a straightforward channel to gain exposure.
INJ holders are voting on the Meridian mainnet upgrade (IIP-701), which could halt the chain for protocol improvements by September 24, 2026.